Aβ-IN-9

• UNSPSC Description:

  Aβ-IN-9 (Compound 6i) is an amyloid-beta aggregation inhibitor. Aβ-IN-9 can inhibit Aβ aggregation to form nano-rod-like structures, thereby preventing β-sheet formation. Aβ-IN-9 can be used for Alzheimer's disease research[1].

• Target Antigen:

  Amyloid-β

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling

• Applications:

  Neuroscience-Neurodegeneration

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/aβ-in-9.html

• Smiles:

  OC1=C(O)C=CC(CCNC(/C=C/C2=CC(O)=C(O)C=C2)=O)=C1

• Molecular Weight:

  315.32

• References & Citations:

  [1]Xu F, et al. Synthesis and evaluation of catecholamine derivatives as amyloid-beta aggregation inhibitors. Bioorg Med Chem Lett. 2024 Jul 15;107:129788.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported